DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Astaxanthin is an investigational drug.
There have been 5 clinical trials for Astaxanthin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 3rd 2020.
The most common disease conditions in clinical trials are Diabetic Retinopathy, Peripheral Nervous System Diseases, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Sheba Medical Center, University of Guadalajara, and Instituto Mexicano del Seguro Social.
There is one US patent protecting this investigational drug and thirteen international patents.
Recent Clinical Trials for Astaxanthin
|The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient||PT SOHO Global Health Tbk||Phase 2/Phase 3|
|The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient||Duta Wacana Christian University||Phase 2/Phase 3|
|Nutraceutical in Cardiovascular Primary Prevention||University Hospital of Ferrara||Phase 2|
Top disease conditions for Astaxanthin
Top clinical trial sponsors for Astaxanthin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Astaxanthin||Get Started Free||Method for increasing the health condition of crustaceans in aquaculture, survival rate and pigmentation||Get Started Free|
|Astaxanthin||Get Started Free||Ready-to-use, stable emulsion||BASF SE (Ludwigshafen am Rhein, DE)||Get Started Free|
|Astaxanthin||Get Started Free||Seaweed-derived cosmetic compositions||Skinergistics Clinical Skin Solutions Inc. (Vancouver, CA)||Get Started Free|
|Astaxanthin||Get Started Free||Animal feed additives comprising a protease and methods of using||Novozymes A/S (Bagsvaerd, DK)||Get Started Free|
|Astaxanthin||Get Started Free||Recombinant microalgae including keto-acyl ACP synthase||Corbion Biotech, Inc. (South San Francisco, CA)||Get Started Free|
|Astaxanthin||Get Started Free||Methods for control of flux in metabolic pathways through enzyme relocation||The Board of Trustees of the Leland Stanford Junior University (Stanford, CA) GreenLight Biosciences, Inc. (Medford, MA)||Get Started Free|
|Astaxanthin||Get Started Free||Method for producing DHA through solid culture and liquid fermentation of Schizochytrium||Xiamen Kingdomway Group Company (Xiamen, Fujian, CN) Inner Mongolia Kingdomway Pharmaceutical Limited (Huhhot, Inner Mongolia, CN)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Astaxanthin||Canada||CA2739361||2028-10-07||Get Started Free|
|Astaxanthin||China||CN102176833||2028-10-07||Get Started Free|
|Astaxanthin||Denmark||DK2343986||2028-10-07||Get Started Free|
|Astaxanthin||European Patent Office||EP2343986||2028-10-07||Get Started Free|
|Astaxanthin||Spain||ES2563640||2028-10-07||Get Started Free|
|Astaxanthin||Japan||JP2012505155||2028-10-07||Get Started Free|
|Astaxanthin||Japan||JP5932334||2028-10-07||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|